Therapeutic effect of dose-dense paclitaxel plus carboplatin with or without bevacizumab for Japanese patients with epithelial ovarian cancer.
Yuki KochiSatoshi HosoyaNozomu YanaiharaChie NagataRie HondaMiwako ShimazakiKota YokosuTakafumi KurodaMotoaki SaitoHiroshi TanabeKyosuke YamadaHirokuni TakanoAikou OkamotoPublished in: International journal of clinical oncology (2024)
Our study may indicate ddTC, BEV, and their combination regimen as the promising first-line chemotherapy option among Japanese patients with advanced EOC.